IL2 and neoplasm: WT, Foxo1-AAA, or Stat4Y693A KP.SIY lung tumor-bearing mice were treated with MSA-IL2 and MSA-IL12 (alone or in combination) on day 7 of tumor growth and monitored daily for survival (Fig. 8e).